Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiation exposure, protection and risk from nuclear medicine procedures.

Literature DB >> 20411257

Radiation exposure, protection and risk from nuclear medicine procedures.

Massimo Salvatori¹, Giovanni Lucignani.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20411257 DOI： 10.1007/s00259-010-1474-5

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

20 in total

1. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.

Authors: Wesley E Bolch; Keith F Eckerman; George Sgouros; Stephen R Thomas
Journal: J Nucl Med Date: 2009-03 Impact factor: 10.057

2. [National survey of radiation protection for workers in positron emission tomography facilities in Japan-1st report: occupational role assignment, radiation exposure to medical workers].

Authors: Hiroshi Watanabe; Tsutomu Satou; Norio Senzui; Fumiharu Kimura; Miyako Sano; Tsunehiko Hoshi; Atsushi Itou; Kouji Naka; Ryou Sagawa
Journal: Nihon Hoshasen Gijutsu Gakkai Zasshi Date: 2009-03-20

3. Subjective perceptions of patients undergoing radioiodine therapy: why should we know about them?

Authors: Lutz S Freudenberg; Stefan P Müller; Andreas Bockisch
Journal: Eur J Nucl Med Mol Imaging Date: 2009-11 Impact factor: 9.236

4. Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility.

Authors: Riccardo Calandrino; Antonella del Vecchio; Annarita Savi; Sergio Todde; Sara Belloli
Journal: Health Phys Date: 2009-10 Impact factor: 1.316

Review 5. Radiation burden in myocardial imaging: an old concern in the new age of hi-tech, hybrid imaging.

Authors: Giovanni Lucignani
Journal: Eur J Nucl Med Mol Imaging Date: 2010-01 Impact factor: 9.236

Review 6. Potential utility of radioprotective agents in the practice of nuclear medicine.

Authors: Seyed Jalal Hosseinimehr
Journal: Cancer Biother Radiopharm Date: 2009-12 Impact factor: 3.099

7. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?

Authors: José Willegaignon de Amorim de Carvalho; Marcelo Sapienza; Carla Ono; Tomoco Watanabe; Maria Inês Guimarães; Ricardo Gutterres; Maria Helena Marechal; Carlos Buchpiguel
Journal: Nucl Med Commun Date: 2009-07 Impact factor: 1.690

Radiation exposure, protection and risk from nuclear medicine procedures.

1. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.

2. [National survey of radiation protection for workers in positron emission tomography facilities in Japan-1st report: occupational role assignment, radiation exposure to medical workers].

3. Subjective perceptions of patients undergoing radioiodine therapy: why should we know about them?

4. Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility.

Review 5. Radiation burden in myocardial imaging: an old concern in the new age of hi-tech, hybrid imaging.

Review 6. Potential utility of radioprotective agents in the practice of nuclear medicine.

7. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?

Review 8. Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

9. Radiation exposure for medical staff performing quantitative coronary perfusion PET with 13N-ammonia.

10. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.

1. Time for radiobiology in the nuclear medicine community.

2. Joint reconstruction of activity and attenuation map using LM SPECT emission data.